Colon Cancer? 85% Survival with THIS $10 Drugstore Pill

Could the secret to beating colon cancer really be a $10 generic pill?

There are two words that describe most mainstream cancer treatments on the market today…

Expensive poison.

They’re charging up to $50,000 for a single round of chemotherapy – a treatment so toxic it practically leaves you on death’s doorstep.

If they could charge you for the air you breathe during chemo, they would.

Meanwhile, there’s a cheap, generic pill sitting on drugstore shelves RIGHT NOW—over-the-counter, no prescription needed—that boosts 10-year survival in Stage III colorectal cancer from 50% to 85%.

It’s backed by years of research – and costs $10 a month.

So why aren’t colon cancer patients ever being told about it?

The drug is cimetidine—you know it as Tagamet, the heartburn medication.

The discovery happened by accident in 1979…

Two patients with metastatic cancer were taking cimetidine for acid reflux. Both went into spontaneous remission.

Doctors thought it was a coincidence. A fluke.

But researchers in Japan got curious. They started digging into how cimetidine might affect cancer cells…

What they discovered changed everything.

Cimetidine blocks something called E-selectin—adhesion molecules on the walls of your blood vessels. When cancer cells break away from a tumor and enter your bloodstream, they use E-selectin like Velcro to stick to vessel walls.

That’s how metastasis happens. Cancer cells circulate… stick… and form NEW tumors in your liver, lungs, or distant organs.

Cimetidine stops that process cold.

By 2002, Japanese researchers had the proof.

They ran a randomized trial with 64 patients who had Stage III colorectal cancer—cancer that had already spread to lymph nodes. All patients received standard chemotherapy.

Half also took 800 mg of cimetidine daily for one year. Half didn’t.

After 10 years, the results were staggering…

…84.6% of the cimetidine group survived. Only 49.8% of the non-cimetidine group did.

But here’s where things get crazy… The more aggressive the cancer, the better cimetidine seems to work.

Some colorectal tumors express a protein called sialyl Lewis antigen. These tumors are particularly aggressive,,, they spread faster and kill more patients.

In those high-risk patients, cimetidine was even more effective…

95.5% survival with cimetidine. Just 35.1% without it.

The evidence isn’t limited to one or two studies. It’s consistent. Repeatable.

So why isn’t every oncologist prescribing this alongside chemotherapy?

Because cimetidine is generic. It’s been off-patent for decades. You can buy it over-the-counter for $10 a month.

There’s zero profit in it.

But you still deserve to know the truth… and to understand all of your options.

Cimetidine is available over-the-counter as Tagamet.

The dose used in the landmark Japanese trial was 800 mg daily for one year, taken alongside standard treatment.

It’s considered safe – it’s not one of those proton pump inhibitor (PPI) stomach acid drugs we’ve warned you about.

If you or someone you love is facing colorectal cancer, this is a conversation worth having with your oncology team or integrative doctor.

Cancer treatment shouldn’t just be about what’s profitable. It should be about what works.

To fighting with every weapon available,

Ray Thatcher
Research Director, Health Sciences Institute

Sources:

• Matsumoto S, Imaeda Y, Umemoto S, Kobayashi K, Suzuki H, Okamoto T. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. British Journal of Cancer. 2002;86(2):161-167. https://pubmed.ncbi.nlm.nih.gov/11870500/
• Adams WJ, Morris DL. Short-course cimetidine and survival with colorectal cancer. Lancet. 1994;344(8939-8940):1768-1769. https://pubmed.ncbi.nlm.nih.gov/7997018/
• Pantziarka P, Bouche G, Meheus L, Sukhatme V, Sukhatme VP. Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent. Ecancermedicalscience. 2014;8:485. https://pubmed.ncbi.nlm.nih.gov/25525463/
• Kubecek O, Soucek O, Vesely S, et al. Cimetidine: an anticancer drug? European Journal of Pharmaceutical Sciences. 2018;42:439-447. https://pubmed.ncbi.nlm.nih.gov/29630589/
• Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T. Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Research. 2000;60(14):3978-3984. https://pubmed.ncbi.nlm.nih.gov/10910059/
• Zheng Y, Wang L, Zhang JP, Yang JY. Effect of cimetidine combined with chemotherapy on patients with gastrointestinal tumor: A meta-analysis. World Journal of Gastroenterology. 2016;22(6):2238-2246. https://pubmed.ncbi.nlm.nih.gov/26834433/